News & Media

Pharmaceutical Veteran Les Leff joins the TruTag Board of Directors

EMERYVILLE, CALIFORNIA ─ October 17, 2017 — TruTag Technologies, a leading security and technology solution provider, is pleased to announce that Les Leff of Polar Investment Fund – as well as the former co-owner and executive vice president of JWS Delavau Co, Inc., and former president of AccuCorp, contract manufacturers of vitamins, minerals and over-the-counter pharmaceuticals – is joining TruTag’s Board of Directors.

Prior to leading both JWS Delavau Co, Inc. and AccuCorp to a successful buyout in 2002, Mr. Leff served in a variety of senior technical liaison, plant management, union negotiation and Food and Drug Administration negotiation roles. He also directed the design and engineering of a state-of-the-art manufacturing facility. He currently leads Polar’s investment in technology, wellness and chemical businesses.

“I am excited to have the opportunity to contribute to this dynamic company,” said Mr. Leff. “I have every confidence that as soon as TruTag’s technologies are adopted, innovative changes will occur throughout the industry.”

“Les is a seasoned pharmaceutical executive with many years of leadership in this dynamic marketplace,” said Michael Bartholomeausz, Chief Executive Officer of TruTag Technologies. “He brings a wealth of experience and operational knowledge that will help push TruTag forward as we expand our footprint in improving the safety, traceability, and authenticity of pharmaceuticals.”

About TruTag Technologies, Inc.

TruTag Technologies, Inc. is a leading security and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for a variety of applications and security solutions, including product identity for food, medicine, secure labels and documents. The company’s highly-specialized nano-porous silica particles extend to precision drug delivery systems for the biopharmaceutical industry. TruTag’s nano-fabrication technology platform is complemented by its advanced hyperspectral imaging solutions, which can be applied to a broad array of market applications from medical diagnostics to machine vision.

TruTag Technologies has been recognized by the SPIE Prism Awards, the Edison Awards, Fast Company, R&D 100, and was selected as a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world. Learn more at

©2017 All rights reserved. TRUTAG and TRUTAGS are registered trademarks of TruTag Technologies, Inc.

Media Contacts:

TruTag Technologies
Paula Page
P: 650.279.3881